John Blenis

Publishes on PI3K/AKT/mTOR signaling in cancer, Protein Kinase Regulation and GTPase Signaling, Melanoma and MAPK Pathways. 337 papers and 68.5k citations.

PubIndex Score98Top 2%How it's scored

🌟#7 Current Senior Leader in PI3K/AKT/mTOR signaling in cancer 🌟#8 Current Senior Leader in Tuberous Sclerosis Complex Research

337Publications

68.5kTotal Citations

#7in PI3K/AKT/mTOR signaling in cancer

First publication: 1980First senior author: 1990

PI3K/AKT/mTOR signaling in cancer Protein Kinase Regulation and GTPase Signaling Melanoma and MAPK Pathways Cancer, Hypoxia, and Metabolism Tuberous Sclerosis Complex Research

Top publicationsby citations

RAS/ERK Signaling Promotes Site-specific Ribosomal Protein S6 Phosphorylation via RSK and Stimulates Cap-dependent Translation

Philippe P. Roux, John Blenis|Journal of Biological Chemistry|2007

Cited by 752

STAT3 Serine Phosphorylation by ERK-Dependent and -Independent Pathways Negatively Modulates Its Tyrosine Phosphorylation

Jongkyeong Chung, John Blenis|Molecular and Cellular Biology|1997

Cited by 622

Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of Tuberin

Andrew R. Tee, John Blenis|Journal of Biological Chemistry|2003

Cited by 214

p90 Ribosomal S6 Kinase and p70 Ribosomal S6 Kinase Link Phosphorylation of the Eukaryotic Chaperonin Containing TCP-1 to Growth Factor, Insulin, and Nutrient Signaling

Yuki Abe, John Blenis|Journal of Biological Chemistry|2009

Cited by 90

Rap1-GTPases control mTORC1 activity by coordinating lysosome organization with amino acid availability

Anders P. Mutvei, John Blenis|Nature Communications|2020

Cited by 81